FME.DE Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:44):

Stats
Today's Volume	435 741
Average Volume	433 463
Market Cap	10.98B
EPS	€0 ( 2024-02-19 )
Next earnings date	( €0.550 ) 2024-05-06
Last Dividend	€1.120 ( 2023-05-17 )
Next Dividend	€0 ( N/A )
P/E	22.01
ATR14	€0.0200 (0.05%)

Volume Correlation

Long: -0.16 (neutral)

Short: -0.94 (very strong negative)

Signal:(40.849) Neutral

Fresenius Medical Care AG Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fresenius Medical Care AG Correlation - Currency/Commodity

-0.21
( neutral )

-0.34
( neutral )

0.00
( neutral )

-0.32
( neutral )

-0.37
( neutral )

-0.15
( neutral )

Fresenius Medical Care AG Financials

Annual	2023
Revenue:	€19.45B
Gross Profit:	€4.93B (25.32 %)
EPS:	€1.700

FY	2023
Revenue:	€19.45B
Gross Profit:	€4.93B (25.32 %)
EPS:	€1.700

FY	2022
Revenue:	€19.40B
Gross Profit:	€5.31B (27.37 %)
EPS:	€2.30

FY	2021
Revenue:	€17.62B
Gross Profit:	€5.08B (28.82 %)
EPS:	€3.30

Financial Reports:

No articles found.

Fresenius Medical Care AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€0 (N/A)	€1.120 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Fresenius Medical Care AG Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 3.61 - Decrease likely (27.80%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.230	2000-05-31
Last Dividend	€1.120	2023-05-17
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	26	--
Total Paid Out	€18.29	--
Avg. Dividend % Per Year	0.00%	--
Score	2.96	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	3.61
Div. Directional Score	7.33	--

Next Divdend (Est)
(2025-02-07)

€1.138 Estimate 3.17 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.96

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
JST.DE	Ex Dividend Junior	2023-05-12	Sporadic	0.00%
TA1.DE	Ex Dividend Knight	2023-06-12	Annually	0.00%
DRW8.DE	Ex Dividend Junior	2023-05-08	Annually	0.00%
MPCK.DE	Ex Dividend Junior	2023-04-28	Sporadic	0.00%
AB9.DE	Ex Dividend Junior	2023-04-28	Sporadic	0.00%
VOW3.DE	Ex Dividend Junior	2023-05-15	Annually	0.00%
FMV.DE	Ex Dividend Junior	2023-08-15	Quarterly	0.00%
OMV.DE	Ex Dividend Knight	2023-06-06	Annually	0.00%
AWC.DE	Ex Dividend Junior	2023-08-07	Quarterly	0.00%
HDI.DE	Ex Dividend Knight	2023-08-30	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0281	1.500	9.44	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0161	1.200	9.46	10.00	[0 - 0.3]
returnOnEquityTTM	0.0398	1.500	-0.669	-1.004	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.424	0.800	7.88	6.30	[1 - 3]
quickRatioTTM	0.916	0.800	9.32	7.45	[0.8 - 2.5]
cashRatioTTM	0.230	1.500	9.84	10.00	[0.2 - 2]
debtRatioTTM	0.355	-1.500	4.08	-6.12	[0 - 0.6]
interestCoverageTTM	3.47	1.000	9.83	9.83	[3 - 30]
operatingCashFlowPerShareTTM	8.96	2.00	7.01	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.63	2.00	6.69	10.00	[0 - 20]
debtEquityRatioTTM	0.885	-1.500	6.46	-9.69	[0 - 2.5]
grossProfitMarginTTM	0.253	1.000	9.11	9.11	[0.2 - 0.8]
operatingProfitMarginTTM	0.0710	1.000	-0.580	-0.580	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.218	1.000	9.90	9.90	[0.2 - 2]
assetTurnoverTTM	0.573	0.800	9.51	7.61	[0.5 - 2]
Total Score				11.04

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	20.29	1.000	8.05	0	[1 - 100]
returnOnEquityTTM	0.0398	2.50	-0.430	-1.004	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.63	2.00	7.79	10.00	[0 - 30]
dividendYielPercentageTTM	2.96	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.96	2.00	7.01	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-4.82	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.135	1.000	9.12	0	[0.1 - 0.5]
Total Score				3.61

Fresenius Medical Care AG

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.